Document is current

Article History

Received: 29 February 2024

Accepted: 5 September 2025

First Online: 8 October 2025

Declarations

:

: This study is registered by King’s College London Research Ethics; MRSP-21/22-25739. All experimental protocols were approved by ethics committee of King’s College London Research Ethics Committee. All methods were carried out in accordance with relevant guidelines and regulations. Each participant received an information leaflet which explained the purpose of the study before they participated. Informed written consent was obtained from each study participants before their interview. Participants were informed that their participation in this study was voluntary and they had the right to withdraw from the study without requiring to provide any rationale. Confidentiality and anonymity of participants were maintained at all stages of the research process.

: The material has not been published in whole or in part elsewhere. The paper is not currently being considered for publication elsewhere. Participants were informed and did not object to the study report being published in an academic journal.

: TS received funding from Cancer Alliance and Health Education England for training cancer multidisciplinary teams (MDTs) in assessment and quality improvement methods in the United Kingdom. TS received consultancy fees from Roche Diagnostics. Infrastructure support for this research for TS was provided by the NIHR London Medtech and In vitro diagnostic Co-operative. The other authors declare that they have no competing interests.